The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
The inspection concluded with no observations
Time to combine innovation, access and technology to deliver positive patient outcomes
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
Subscribe To Our Newsletter & Stay Updated
